Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13902
Abstract: Agomelatine is an antidepressant for major depressive disorders. It undergoes extensive firstāpass hepatic metabolism and displays irregular absorption profiles and large interindividual variability (IIV) and interoccasion variability of pharmacokinetics. The objective of this study was…
read more here.
Keywords:
pharmacokinetic model;
population pharmacokinetic;
model agomelatine;
semiphysiological population ... See more keywords